This Policy Position Paper explains this concept and the advantages it offers to the long-term sustainability of Europe’s healthcare systems. We therefore call for appropriate legislative/policy measures to promote generic substitution at national level, and for EU-level policymakers to support this process.
Celesio believes that pharmacists are ideally placed to make significant cost savings and outcomes improvements to support public healthcare budgets. One area where immediate savings are possible is pharmacist-led generic substitution.
- Ronan Brett
- Director Public Affairs McKesson Europe
- +49 711 5001-615